Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not an Insider? Subscribe now for unlimited access to online articles.

Emily Singer

A View from Emily Singer

A New Approach to Boosting Good Cholesterol

Activating longevity-linked genes could protect against atherosclerosis.

  • October 12, 2007

Hoping to repeat the blockbuster success of cholesterol-lowering statins, pharmaceutical companies have been doggedly searching for a new kind of cholesterol drug–one that pumps up levels of heart-healthy good cholesterol. High levels of bad cholesterol (LDL) build up in the arteries and lead to heart attacks, while good cholesterol (HDL) appears to protect against cardiovascular disease, likely by flushing away its harmful cousin.

But finding such drugs has been a challenge. One promising, high-profile candidate from Pfizer, called torcetrapib, was pulled from development last year when clinical trials revealed serious safety concerns. And derivatives of niacin, a B vitamin shown to boost good cholesterol, has problematic side effects that stop many people from taking the drug.

New research from Leonard Guarente at MIT could provide a new target for HDL-raising drugs: the sirtuins, a class of genes linked to longevity. (See “The Enthusiast” and “The Fountain of Health.”) According to Guarente, SIRT1 can promote formation of good cholesterol and lowers the cholesterol burden in tissues by removing excess cholesterol from those tissues and flushing it out of the body. The findings were published today in the journal Molecular Cell.

Sirtris Pharmaceuticals, a company based in Cambridge, MA, that’s developing novel compounds that target the sirtuins, has already licensed the patent covering the research from MIT. Sirtris already has one sirtuin-activating compound in early clinical trials for diabetes.

Become an MIT Technology Review Insider for in-depth analysis and unparalleled perspective.

Subscribe today
More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe and become an Insider.
  • Insider Plus {! insider.prices.plus !}* Best Value

    {! insider.display.menuOptionsLabel !}

    Everything included in Insider Basic, plus the digital magazine, extensive archive, ad-free web experience, and discounts to partner offerings and MIT Technology Review events.

    See details+

    What's Included

    Unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

    Bimonthly print magazine (6 issues per year)

    Bimonthly digital/PDF edition

    Access to the magazine PDF archive—thousands of articles going back to 1899 at your fingertips

    Special interest publications

    Discount to MIT Technology Review events

    Special discounts to select partner offerings

    Ad-free web experience

  • Insider Basic {! insider.prices.basic !}*

    {! insider.display.menuOptionsLabel !}

    Six issues of our award winning print magazine, unlimited online access plus The Download with the top tech stories delivered daily to your inbox.

    See details+

    What's Included

    Unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

    Bimonthly print magazine (6 issues per year)

  • Insider Online Only {! insider.prices.online !}*

    {! insider.display.menuOptionsLabel !}

    Unlimited online access including articles and video, plus The Download with the top tech stories delivered daily to your inbox.

    See details+

    What's Included

    Unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

/3
You've read of three free articles this month. for unlimited online access. You've read of three free articles this month. for unlimited online access. This is your last free article this month. for unlimited online access. You've read all your free articles this month. for unlimited online access. You've read of three free articles this month. for more, or for unlimited online access. for two more free articles, or for unlimited online access.